NEW HAVEN, Conn., Sept. 3, 2009 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Michael D. Kishbauch, President and Chief Executive Officer, will give a corporate presentation at the upcoming Thomas Weisel Partners Annual Healthcare Conference on Wednesday, September 9, 2009 at 2:40 p.m. EDT at the Four Seasons Hotel in Boston.
